---
title: "Sun Pharma Advanced Research Company Ltd (SPARC) — Share Price, Financials & Analysis"
symbol: "SPARC"
company: "Sun Pharma Advanced Research Company Ltd"
canonical: "https://tapetide.com/stocks/SPARC"
isin: "INE232I01014"
nse_symbol: "SPARC"
bse_code: "532872"
sector: "Healthcare"
industry: "Pharmaceuticals & Biotechnology"
market_cap_cr: 6274.2
generated_at: "2026-09-13T18:57:16.944Z"
---

# Sun Pharma Advanced Research Company Ltd (SPARC)

Canonical page: https://tapetide.com/stocks/SPARC

## Company

- **NSE Symbol:** SPARC
- **BSE Code:** 532872
- **ISIN:** INE232I01014
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals & Biotechnology
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2007-07-18
- **CEO:** Mr. Anilkumar Raghavan
- **Employees:** 316
- **Face Value:** ₹1
- **F&O Eligible:** No
- **Website:** sparc.life

## About

Sun Pharma Advanced Research Company Ltd is engaged in the business of research and development (R&D) of pharmaceutical products.[1]

## Latest Price

- **Price:** ₹196.01
- **Change:** -0.9 (-0.46%)
- **Open:** ₹196.89
- **Day High:** ₹197.55
- **Day Low:** ₹192.56
- **Previous Close:** ₹196.91
- **Volume:** 475527
- **As Of:** 2026-09-11T10:25:50+00:00

## Key Fundamentals

Observed at 2026-09-11T04:40:06.868973Z.

- **Market Cap:** ₹6274.2 Cr
- **Classification:** Microcap
- **P/E (reported):** 4
- **P/E (TTM):** 4.02
- **EPS (TTM):** ₹48.79
- **EPS (reported):** ₹0
- **Book Value:** ₹41.26
- **Price to Book:** 4.77
- **Dividend Yield:** 0%
- **ROE:** 116.01%
- **ROCE:** 112.03%
- **Debt to Equity:** 0.42
- **Revenue (yearly):** ₹1890.1 Cr
- **Net Income:** ₹1553.2 Cr
- **EBITDA:** ₹1609.7 Cr
- **52-Week High:** ₹289
- **52-Week Low:** ₹108
- **RSI (14):** 43.45

## Tapetide Score

- **Score:** 53 / 100
- **Score date:** 2026-09-04
- **Archetype:** Trend Ahead of Fundamentals
- **What it means:** The price trend is running ahead of what the financials currently support. Moves like this depend on the fundamentals catching up; check what would have to be true for that.
- **Pillar profile:** Quality: Weak · Valuation: Fair · Momentum: Rising
- **Percentile:** 61 (of 4473 scored stocks)
- **Confidence:** 95%
- **Data coverage:** 90%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 54.23 | 9% |
| growth | 98.9 | 9% |
| momentum | 73.3 | 12% |
| ownership | 65.93 | 24% |
| quality | 16.64 | 22% |
| valuation | 52.26 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company has delivered good profit growth of 65.3% CAGR over last 5 years

### Weaknesses

- Stock is trading at 4.77 times its book value
- Working capital days have increased from -770 days to 214 days

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 33.73% | 44.36% | -516.94% |
| ebitda margin growth | 84.15% | -119.49% | -124% | — |
| net income growth | -101.18% | -553.49% | 108% | 65% |
| revenue growth | 324% | — | 99% | 49% |
| roce | -100.71% | -87.01% | -172.72% | — |
| roe | -101.18% | -26.52% | -11.34% | — |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 21 | 14 | 17 | 17 | 13 | 15 | 27 | 10 | 8 | 8 | 1853 | 40 |
| Expenses | 113 | 116 | 124 | 112 | 117 | 89 | 81 | 62 | 74 | 65 | 80 | 74 |
| Operating Profit | -91 | -103 | -108 | -95 | -104 | -74 | -54 | -52 | -66 | -57 | 1773 | -34 |
| OPM % | -432 | -740 | -649 | -566 | -808 | -499 | -198 | -543 | -838 | -673 | 96 | -86 |
| Other Income | 8 | 6 | 4 | 2 | 0 | 0 | 0 | 9 | 0 | -12 | 2 | 24 |
| Interest | 0 | 0 | 1 | 1 | 1 | 3 | 5 | 6 | 8 | 9 | 12 | 8 |
| Depreciation | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 2 |
| Profit before tax | -86 | -100 | -107 | -97 | -108 | -80 | -61 | -52 | -76 | -81 | 1761 | -21 |
| Tax % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | -86 | -100 | -107 | -97 | -108 | -80 | -61 | -52 | -76 | -81 | 1761 | -21 |
| EPS in Rs | -2.66 | -3.07 | -3.29 | -2.98 | -3.32 | -2.46 | -1.88 | -1.6 | -2.34 | -2.48 | 54.26 | -0.65 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 78 | 183 | 77 | 253 | 137 | 239 | 76 | 72 | 1879 | 1909 |
| Expenses | 321 | 334 | 387 | 388 | 324 | 453 | 479 | 399 | 281 | 294 |
| Operating Profit | -243 | -151 | -310 | -135 | -187 | -214 | -404 | -327 | 1598 | 1616 |
| OPM % | -310 | -83 | -404 | -53 | -136 | -90 | -534 | -456 | 85 | 85 |
| Other Income | 54 | 14 | 10 | 5 | 7 | 11 | 29 | 2 | -2 | 13 |
| Interest | 0 | 0 | 3 | 11 | 13 | 8 | 2 | 9 | 34 | 36 |
| Depreciation | 8 | 8 | 9 | 11 | 10 | 12 | 12 | 11 | 10 | 10 |
| Profit before tax | -197 | -145 | -312 | -151 | -203 | -223 | -388 | -345 | 1552 | 1583 |
| Tax % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |
| Net Profit | -197 | -145 | -312 | -151 | -203 | -223 | -388 | -345 | 1552 | 1583 |
| EPS in Rs | -7.85 | -5.55 | -11.92 | -5.77 | -7.48 | -6.86 | -11.96 | -10.64 | 47.83 | 48.79 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 25 | 25 | 26 | 26 | 26 | 27 | 32 | 32 | 32 | 32 |
| Reserves | 133 | 160 | 270 | -45 | -194 | 4 | 480 | 92 | -253 | 1301 |
| Borrowings | 3 | 2 | 2 | 67 | 236 | 79 | 16 | 56 | 265 | 559 |
| Other Liabilities | 111 | 122 | 101 | 224 | 162 | 170 | 302 | 305 | 284 | 275 |
| Total Liabilities | 273 | 309 | 398 | 273 | 230 | 280 | 830 | 486 | 329 | 2168 |
| Fixed Assets | 69 | 52 | 58 | 104 | 91 | 92 | 106 | 103 | 95 | 85 |
| CWIP | 1 | 3 | 24 | 32 | 5 | 26 | 27 | 44 | 54 | 72 |
| Investments | 10 | 108 | 211 | 8 | 6 | 12 | 291 | 2 | 0 | 0 |
| Other Assets | 192 | 146 | 106 | 128 | 127 | 150 | 406 | 338 | 179 | 2011 |
| Total Assets | 273 | 309 | 398 | 273 | 230 | 280 | 830 | 486 | 329 | 2168 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | -128 | -183 | -172 | -211 | -152 | -208 | -69 | -429 | -362 | -239 |
| Cash from Investing Activity | -7 | -105 | -102 | 155 | 2 | -29 | -548 | 391 | 158 | -24 |
| Cash from Financing Activity | 194 | 224 | 274 | 55 | 159 | 229 | 617 | 43 | 201 | 262 |
| Net Cash Flow | 60 | -63 | 0 | 0 | 9 | -8 | -1 | 4 | -4 | -1 |
| Free Cash Flow | -136 | -200 | -184 | -264 | -153 | -233 | -84 | -455 | -372 | -262 |
| CFO/OP | 88 | 71 | 111 | 65 | 111 | 114 | 35 | 105 | 114 | -17 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 78 | 82 | 20 | 76 | 25 | 74 | 50 | 75 | 82 | 2 |
| Inventory Days | 0 | 0 | 0 | 0 | 0 | 0 | — | — | — | — |
| Cash Conversion Cycle | 78 | 82 | 20 | 76 | 25 | 74 | 50 | 75 | 82 | 2 |
| Working Capital Days | -60 | -232 | -98 | -842 | -268 | -301 | -193 | -746 | -1778 | 214 |
| ROCE % | -94 | -143 | -62 | -183 | -242 | -218 | -67 | -109 | -298 | 165 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 65.67% | 65.67% | 65.67% | 65.67% | 65.67% | 65.67% | 65.67% | 65.67% | 65.67% | 65.67% | 65.67% | 65.67% |
| FIIs | 3.67% | 3.3% | 3.23% | 2.64% | 2.15% | 2.23% | 1.45% | 1.47% | 1.76% | 2.04% | 2.04% | 3.9% |
| DIIs | 0.23% | 0.81% | 0.82% | 0.18% | 0.23% | 0.64% | 1.13% | 0.97% | 1.05% | 0.78% | 0.88% | 0.09% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 15.9% | 16.09% | 16.11% | 18.91% | 19.2% | 18.89% | 18.99% | 19.15% | 18.94% | 19.2% | 16.81% | 18.57% |
| Others | 14.53% | 14.13% | 14.17% | 12.6% | 12.75% | 12.58% | 12.76% | 12.73% | 12.59% | 12.3% | 14.6% | 11.76% |
| No. of Shareholders | 101433 | 103990 | 102743 | 125184 | 128205 | 131034 | 142864 | 140724 | 136997 | 144810 | 140625 | 141957 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Sell
- **Buy / Neutral / Sell:** 4 / 7 / 8

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 200.05 | Sell |
| EMA (10) | 199.52 | Sell |
| SMA (20) | 198.34 | Sell |
| EMA (20) | 201.1 | Sell |
| SMA (50) | 215.6 | Sell |
| EMA (50) | 205.96 | Sell |
| SMA (100) | 205.99 | Sell |
| EMA (100) | 198.76 | Sell |
| SMA (200) | 169.29 | Buy |
| EMA (200) | 182.18 | Buy |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 42.68 | Neutral |
| MACD (12,26,9) | -2.94 | Buy |
| Stochastic (14,3,3) | 32.59 | Neutral |
| ADX (14) | 18.08 | Neutral |
| Williams %R (14) | -77.6 | Neutral |
| ATR (14) | 7.85 | High Volatility |
| ROC (12) | 0.85 | Buy |
| Stoch RSI (14) | 43.2 | Neutral |
| UO (7,14,28) | 40.32 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-08-13 | [Filing Of Application For Reclassification With Stock Exchanges](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c25d28dd-35e4-4274-8e3b-e2b2efacdab7.pdf) |
| 2026-08-11 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=06626beb-a5f7-45c1-9c9c-3510c754cc37.pdf) |
| 2026-08-10 | [Board Meeting Outcome for Outcome Of The Board Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=604f45e5-65f0-4e3e-b234-d710441e21b6.pdf) |
| 2026-08-10 | [Announcement under Regulation 30 (LODR)-Monitoring Agency Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=24cb4d83-94d3-41cb-afc6-478082ee483f.pdf) |
| 2026-08-10 | [Shareholder Meeting / Postal Ballot-Outcome of AGM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=daebb526-fb58-4387-8696-50161c8c37bf.pdf) |
| 2026-08-03 | [Board Meeting Intimation for Approval Of Unaudited Standalone And Consolidated Financial Results For The Quarter Ended June 30 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=70db7aa2-761c-4850-91e0-2ed5a0504901.pdf) |
| 2026-07-27 | [Intimation For Receipt Of Requests For Reclassification Of Shareholder Category](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4ae0e893-533b-461c-84e3-8f492ed372ae.pdf) |
| 2026-07-17 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e39dc718-6532-41d1-ae13-94f99a398234.pdf) |
| 2026-07-16 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d613e9d5-80ef-4e80-96ae-455b4ca8043c.pdf) |
| 2026-07-16 | [Notice Of 21St Annual General Meeting To Be Held On August 10 2026 Along With The Annual Report For FY 26](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6b01b1c1-8c88-481e-9512-d1538b984c06.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-10 | [Unaudited Financial Results For The Quarter Ended June 30 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=284720dd-565c-4ed6-acac-9a17ce40fba4.pdf) |
| 2026-05-18 | [Audited Financial Results For The Quarter And Year Ended March 31 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cb1886fa-d9ce-40d7-a116-0e8fbe2e8011.pdf) |
| 2026-02-09 | [Unaudited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended December 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a3b8f547-828c-4113-af6b-c5b2914c9585.pdf) |
| 2025-11-10 | [Financial Results For The Quarter And Half-Year Ended September 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8f033966-b7ce-41ec-95a2-edac70753e53.pdf) |
| 2025-08-04 | [Unaudited Financial Results For The Quarter Ended June 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c97ddc8d-c5c8-4fa1-90fe-23c2abc6305d.pdf) |
| 2025-05-19 | [Audited Financial Results For The Quarter And Financial Year Ended March 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c951fc07-6a46-47af-a83f-3577989f9f15.pdf) |
| 2025-02-10 | [Financial Results For The Quarter And Nine Months Ended December 31 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=912548eb-9cea-49a9-9031-48caffa8c961.pdf) |
| 2024-11-04 | [Board Meeting Outcome for Outcome Of Board Meeting For Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e987b70e-f55b-4ef9-9a83-725cdea53d09.pdf) |
| 2024-11-04 | [Financial Results For The Quarter And Half Year Ended September 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=222fd8a8-5f42-499c-a19c-e833de0680ee.pdf) |
| 2024-11-04 | [Financial Results For The Quarter And Half Year Ended September 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3f39b1db-6778-44f6-ac65-728d0d9773eb.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 9 Feb - Q3/9M FY26 results: consolidated nine-month loss ₹20,814L; exceptional ₹1,236L; PRV granted Feb 03, 2026. | [Board Meeting Outcome for For Approval Of Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2025 9 Feb - Q3/9M FY26 results: consolidated nine-month loss ₹20,814L; exceptional ₹1,236L; PRV granted Feb 03, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/5819236c-2b05-4b5f-9d67-df9890d69976.pdf) |
| 8h - Board to approve audited FY26 standalone and consolidated results on May 18, 2026. | [Board Meeting Intimation for Approval Of Audited Financial Results For The Quarter And Financial Year Ended March 31, 2026 8h - Board to approve audited FY26 standalone and consolidated results on May 18, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/bd27f786-1154-4647-bbeb-af2aa56a246d.pdf) |
| 6 Apr - Submitted Regulation 74(5) confirmation certificate for quarter ended March 31, 2026. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 6 Apr - Submitted Regulation 74(5) confirmation certificate for quarter ended March 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2d0fd44c-5a16-4347-a6e9-124befd9f9c4.pdf) |
| 30 Apr - SPARC to sell FDA priority review voucher for US$195 million, subject to closing conditions. | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 30 Apr - SPARC to sell FDA priority review voucher for US$195 million, subject to closing conditions.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ad0b69d5-b144-4c06-9907-6c4a230d4949.pdf) |
| 30 Apr - SPARC to sell FDA priority review voucher for US$195 million, subject to closing conditions. | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 30 Apr - SPARC to sell FDA priority review voucher for US$195 million, subject to closing conditions.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/ad0b69d5-b144-4c06-9907-6c4a230d4949.pdf) |
| 3 Apr - Dr. Shravanti Bhowmik resigned as Head of Operations Management effective March 31, 2026. | [Announcement under Regulation 30 (LODR)-Change in Management 3 Apr - Dr. Shravanti Bhowmik resigned as Head of Operations Management effective March 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d5533fa7-423b-4416-a1e3-edeea54bd33f.pdf) |
| 27 Mar - Dr. Shravanti Bhowmik resigns effective March 31, 2026; Narendra Lakkad appointed Senior Management effective April 1, 2026 and Head – Corporate Development and Operations Management. | [Announcement under Regulation 30 (LODR)-Change in Management 27 Mar - Dr. Shravanti Bhowmik resigns effective March 31, 2026; Narendra Lakkad appointed Senior Management effective April 1, 2026 and Head – Corporate Development and Operations Management.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/89445f03-e3f5-4403-9b2b-6ddfd04c0986.pdf) |
| 27 Mar - Confirms Reg 30 compliance; no undisclosed information; clarification regarding increase in trading volume. | [Clarification Regarding Increase In Volume 27 Mar - Confirms Reg 30 compliance; no undisclosed information; clarification regarding increase in trading volume.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/788ea702-0ec5-43de-8f7f-f28096e7bc57.pdf) |
| 26 Mar - Trading window closed Apr 1, 2026 until 48 hours after audited FY2025-26 results; board date to be intimated. | [Closure of Trading Window 26 Mar - Trading window closed Apr 1, 2026 until 48 hours after audited FY2025-26 results; board date to be intimated.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1dd1c12f-c681-4666-a780-85f90ed599a2.pdf) |
| 24 Feb - Addendum to valuation report dated Feb 24, 2026 clarifying DCF exclusion and financial statement reference. | [Addendum To The Valuation Report Issued On January 14, 2026 24 Feb - Addendum to valuation report dated Feb 24, 2026 clarifying DCF exclusion and financial statement reference.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b177cbbe-88d9-43a8-a455-6f4e40af350a.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2026-01-13 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=203be15c-b6fe-43e3-ab7e-4e2f5439364a.pdf) |
| 2026-01-08 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3e382a0b-33a2-48ff-8bfa-b1d6fc022ec7.pdf) |
| 2024-01-07 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e69cb879-5c80-4f81-8bf9-f714dfdd88a3.pdf) |
| 2024-01-06 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=32731358-55b3-41b7-aa2a-deee642ccc82.pdf) |
| 2023-11-10 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0c998102-f05a-4d5c-ada2-330051ba5b15.pdf) |
| 2023-11-02 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bfa5c814-4b2e-48ec-8768-22e1e37d5b36.pdf) |
| 2022-10-28 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4e36f649-9ca9-4826-a409-3fc5aad3e1b6.pdf) |
| 2022-10-17 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=154d24e8-814e-43b5-a901-dd0a00512075.pdf) |
| 2022-10-13 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=253068b2-f76e-4e29-81ed-36489dc82f4a.pdf) |
| 2021-12-28 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dfaf9b21-5781-47df-a368-228c8cae0b8f.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Financial Year 2011 from nse](https://archives.nseindia.com/annual_reports/AR_SPARC_2010_2011_18072011105556.zip) |
| from bse | [Annual Report 2026 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d613e9d5-80ef-4e80-96ae-455b4ca8043c.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/be81adfc-8f93-4536-aa89-1123005f42fb.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/84fa0e2c-0310-4041-90d9-720d3db5b326.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7405c1bc-58e3-44b7-9235-0cf5b5a88ef5.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/532872/75004532872.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/532872/71975532872.pdf) |
| from bse | [Annual Report 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/532872/66728532872.pdf) |
| from bse | [Annual Report 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/532872/5328720319.pdf) |
| from bse | [Annual Report 2018 from bse](https://www.bseindia.com/bseplus/AnnualReport/532872/5328720318.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Sep 2020 | [Concall - Sep 2020](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f854ce7e-c204-4c06-bd55-469c9e64fc3f.pdf) |
| Sep 2020 | [Concall - Sep 2020](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f854ce7e-c204-4c06-bd55-469c9e64fc3f.pdf) |
| Sep 2019 | [Concall - Sep 2019](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=51aa1c4b-f524-4f33-8fc2-25d935249fd5.pdf) |
| Sep 2019 | [Concall - Sep 2019](https://www.bseindia.com/xml-data/corpfiling/AttachHis/51aa1c4b-f524-4f33-8fc2-25d935249fd5.pdf) |
| Sep 2018 | [Concall - Sep 2018](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6c4fc0b8-ce6a-49d5-ade6-2390bd3f2bde.pdf) |
| Sep 2018 | [Concall - Sep 2018](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c093f4d2-f4c2-436b-b85c-e184c40b0a87.pdf) |
| Sep 2018 | [Concall - Sep 2018](https://www.bseindia.com/xml-data/corpfiling/CorpAttachment/2018/9/6c4fc0b8-ce6a-49d5-ade6-2390bd3f2bde.pdf) |
| Sep 2018 | [Concall - Sep 2018](https://www.bseindia.com/xml-data/corpfiling/CorpAttachment/2018/9/c093f4d2-f4c2-436b-b85c-e184c40b0a87.pdf) |
| Oct 2022 | [Concall - Oct 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4e36f649-9ca9-4826-a409-3fc5aad3e1b6.pdf) |
| Nov 2023 | [Concall - Nov 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0c998102-f05a-4d5c-ada2-330051ba5b15.pdf) |

### Earnings Call Transcripts

| Date | Document |
| --- | --- |
| 2024-01-12 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=158dd371-9f83-4506-8ec9-3014ca75ff8c.pdf) |

### Earnings Call Recordings

| Date | Document |
| --- | --- |
| 2023-11-03 | [Audio Playback Of The Investor Presentation For Update On Clinical Programs And R&D Pipeline](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dfa000cb-a5f1-4efd-9845-cea56fe7eeb3.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:57:16.944Z.